← Back
$MIRM All transactions

Mirum Pharmaceuticals, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

1,041

Price

$0

Filed

Jul 3

Insider

Name

Howe Jolanda

Title

SVP, GLOBAL CONTROLLER

CIK

0001974200

Roles

Officer

Transaction Details

Transaction Date

2025-07-01

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). | Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. | Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024. | The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023.

Filing Info

Accession No.

0001415889-25-019378

Form Type

4

Issuer CIK

0001759425

Howe Jolanda's History

Date Ticker Type Value
2026-02-02 MIRM $100K
2026-01-31 MIRM M
2026-01-31 MIRM M $0
2026-01-28 MIRM A $0
2026-01-28 MIRM A $0
2026-01-28 MIRM A $0
2026-01-26 MIRM $81K
2026-01-23 MIRM M
2026-01-23 MIRM M $0
2026-01-22 MIRM $86K

Other Insiders at MIRM (90d)

Insider Bought Sold Last
Heron Patrick J $9.0M 2026-01-23
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
$101K 2026-01-28
Ramasastry Saira $194K 2026-04-15
Peetz Christopher
CHIEF EXECUTIVE OFFICER
$1.6M 2026-02-02
Radovich Peter
PRESIDENT AND COO
$574K 2026-02-02
Quan Joanne
CHIEF MEDICAL OFFICER
2026-01-28
Howe Jolanda
SVP, GLOBAL CONTROLLER
$181K 2026-02-02